Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 55
Filter
1.
New Microbes New Infect ; 41: 100845, 2021 May.
Article in English | MEDLINE | ID: mdl-34035924

ABSTRACT

The gut microbiome of humans comprises a diverse group of trillions of microorganisms including symbiotic organisms, opportunistic pathogens and commensal organisms. This microbiota plays a major role in digesting food; it also helps with absorbing and synthesizing some nutrients and releases their metabolites, which may deliver a variety of growth-promoting and growth-inhibiting factors that influence human health either directly or indirectly. The balance between microbial species, especially those responsible for the fermentation of different substrates within the microbial community, which are in the majority, depends on daily diet. Therefore, an unbalanced diet may lead to the progression and development of human diseases. These include metabolic and inflammatory disorders, cancer and depression, as well as infant health and longevity. We provide an overview of the effect of diet on the human microbiome and assess the related risk of disease development.

2.
J Thromb Haemost ; 19(5): 1259-1270, 2021 05.
Article in English | MEDLINE | ID: mdl-33636042

ABSTRACT

BACKGROUND: Dabigatran etexilate (DE), a direct oral thrombin inhibitor, has been evaluated in children with venous thromboembolism (VTE) using oral solution, pellets, or capsules. OBJECTIVES: This study evaluated DE pharmacokinetics (PK) in children with VTE and the appropriateness of a DE pediatric age- and weight-based dosing algorithm. PATIENTS/METHODS: A population PK model was fitted to data from four single-arm and one randomized, comparative pediatric VTE studies (358 children aged birth to <18 years; 2748 PK observations) and one healthy-adult study (32 males aged <40 years; 1523 PK observations) using nonlinear mixed-effects modeling. A stepwise, covariate, model-building procedure evaluated the influence of covariates (e.g., age, body weight, body surface area [BSA]-normalized renal function, and sex). The final model was used to evaluate the pediatric dosing algorithm, with simulations comparing pediatric trough exposure with reference exposure defined for the pediatric studies. RESULTS: The population PK of dabigatran was adequately described by a two-compartment model with first-order elimination and absorption. Age, weight, BSA-normalized renal function, and sex were statistically significant covariates (all P < .05). Apparent clearance increased with age (independently of body weight), diminished with decreasing BSA-normalized renal function, and was lower in females than males. All disposition parameters increased with body weight escalation (allometric scaling). Simulations confirmed that for all DE formulations, the final pediatric dosing algorithms achieved reference exposure without dose adjustment. CONCLUSIONS: Using a population PK model of DE for children with VTE, simulations showed that the final dosing algorithms were appropriate for all DE formulations; no dose titration was needed.


Subject(s)
Dabigatran , Venous Thromboembolism , Adolescent , Adult , Antithrombins , Body Weight , Child , Computer Simulation , Female , Humans , Male , Venous Thromboembolism/diagnosis , Venous Thromboembolism/drug therapy
3.
J Clin Pharmacol ; 61(1): 116-124, 2021 01.
Article in English | MEDLINE | ID: mdl-32729150

ABSTRACT

The integrated minimal model allows assessment of clinical diagnosis indices, for example, insulin sensitivity (SI ) and glucose effectiveness (SG ), from data of the insulin-modified intravenous glucose tolerance test (IVGTT), which is laborious with an intense sampling schedule, up to 32 samples. The aim of this study was to propose a more informative, although less laborious, IVGTT design to be used for model-based assessment of SI and SG . The IVGTT design was optimized simultaneously for all design variables: glucose and insulin infusion doses, time of glucose dose and start of insulin infusion, insulin infusion duration, sampling times, and number of samples. Design efficiency was used to compare among different designs. The simultaneously optimized designs showed a profound higher efficiency than both standard rich (32 samples) and sparse (10 samples) designs. The optimized designs, after removing replicate sample times, were 1.9 and 7.1 times more efficient than the standard rich and sparse designs, respectively. After including practical aspects of the designs, for example, sufficient duration between samples and avoidance of prolonged hypoglycemia, we propose 2 practical designs with fewer sampling times and lower input of glucose and insulin than standard designs, constrained to prevent hypoglycemia. The optimized practical rich design is equally efficient in assessing SI and SG as the rich standard design, but with half the number of the samples, while the optimized practical sparse design has 1 less sample and requires 4.6 times fewer individuals for equal certainty when assessing SI and SG than the sparse standard design.


Subject(s)
Glucose Tolerance Test/methods , Insulin Resistance/physiology , Drug Administration Schedule , Glucose/administration & dosage , Glucose/pharmacokinetics , Humans , Insulin/administration & dosage , Insulin/pharmacokinetics , Models, Biological
4.
Eur J Pharm Sci ; 134: 7-19, 2019 Jun 15.
Article in English | MEDLINE | ID: mdl-30978382

ABSTRACT

This paper describes the improved integrated minimal model for healthy subjects and patients with type 2 diabetes and the work leading up to this model. The original integrated minimal model characterizes simultaneously glucose and insulin following intravenous glucose tolerance test (IVGTT) in healthy subjects and provides apart from estimates of indices for insulin sensitivity (Si) and glucose effectiveness (SG), also full simulation capabilities. However, this model was developed using IVGTT data of total glucose and consequently, the model cannot separate hepatic glucose production from glucose disposal. By fitting the original integrated minimal model to IVGTT data of labelled and total glucose, we show that all parameter estimates of the glucose sub-model were significantly different between the fits, in particular, SG, which was ~3 fold higher with total, compared to labelled glucose. In addition, the time profiles of hepatic glucose production, obtained from the model, were unphysiological in most subjects. To correct these flaws, we developed the improved integrated minimal model based on the non-integrated, two-compartment minimal model. The improved integrated minimal model showed physiologically plausible dynamic time profiles of hepatic glucose production and all parameter estimates were compatible with those reported in original publication of the non-integrated minimal model. The integrated minimal model offers the benefits of the original integrated minimal model with simulation capabilities, in presence of endogenous insulin, combined with the benefits of the non-integrated minimal model, which accurately estimates the clinical indices of insulin sensitivity and glucose effectiveness. In addition, the improved integrated minimal model describes, apart from healthy subjects, also patients with type 2 diabetes.


Subject(s)
Blood Glucose/biosynthesis , Blood Glucose/metabolism , Insulin/blood , Diabetes Mellitus, Type 2 , Glucose/biosynthesis , Glucose/metabolism , Glucose Tolerance Test , Healthy Volunteers , Humans , Insulin Resistance , Liver , Mathematics , Models, Biological
5.
Pharm Res ; 36(6): 86, 2019 Apr 17.
Article in English | MEDLINE | ID: mdl-31001701

ABSTRACT

PURPOSE: For some biological systems, there exist several models with somewhat different features and perspectives. We propose an evaluation method for NLME models by analyzing real and simulated data from the model of main interest using a structurally different, but similar, NLME model. We showcase this method using the Integrated Glucose Insulin (IGI) model and the Integrated Minimal Model (IMM). Additionally, we try to map parameters carrying similar information between the two models. METHODS: A bootstrap of real data and simulated datasets from both the IMM and IGI models were analyzed with the two models. Important parameters of the IMM were mapped to IGI parameters using a large IMM simulated dataset analyzed under the IGI model. RESULTS: Comparison of the parameters estimated from real data and data simulated with the IMM and analyzed with the IGI model demonstrated differences between real and IMM-simulated data. Comparison of the parameters estimated from real data and data simulated with the IGI model and analyzed with the IMM also demonstrated differences but to a lower extent. The strongest parameter correlations were found for: insulin-dependent glucose clearance (IGI) ~ insulin sensitivity (IMM); insulin-independent glucose clearance (IGI) ~ glucose effectiveness (IMM); and insulin effect parameter (IGI) ~ insulin action (IMM). CONCLUSIONS: We demonstrated a new approach to investigate models' ability to simulate real-life-like data, and the information captured in each model in comparison to real data, and the IMM clinically used parameters were successfully mapped to their corresponding IGI parameters.


Subject(s)
Blood Glucose/metabolism , Homeostasis/physiology , Insulin/metabolism , Models, Molecular , Computational Biology , Databases, Factual , Glucose Tolerance Test , Humans , Insulin Resistance , Insulin Secretion , Models, Biological
6.
AAPS J ; 21(3): 34, 2019 02 27.
Article in English | MEDLINE | ID: mdl-30815754

ABSTRACT

Nonlinear mixed effects models are widely used to describe longitudinal data to improve the efficiency of drug development process or increase the understanding of the studied disease. In such settings, the appropriateness of the modeling assumptions is critical in order to draw correct conclusions and must be carefully assessed for any substantial violations. Here, we propose a new method for structure model assessment, based on assessment of bias in conditional weighted residuals (CWRES). We illustrate this method by assessing prediction bias in two integrated models for glucose homeostasis, the integrated glucose-insulin (IGI) model, and the integrated minimal model (IMM). One dataset was simulated from each model then analyzed with the two models. CWRES outputted from each model fitting were modeled to capture systematic trends in CWRES as well as the magnitude of structural model misspecifications in terms of difference in objective function values (ΔOFVBias). The estimates of CWRES bias were used to calculate the corresponding bias in conditional predictions by the inversion of first-order conditional estimation method's covariance equation. Time, glucose, and insulin concentration predictions were the investigated independent variables. The new method identified correctly the bias in glucose sub-model of the integrated minimal model (IMM), when this bias occurred, and calculated the absolute and proportional magnitude of the resulting bias. CWRES bias versus the independent variables agreed well with the true trends of misspecification. This method is fast easily automated diagnostic tool for model development/evaluation process, and it is already implemented as part of the Perl-speaks-NONMEM software.


Subject(s)
Drug Development/methods , Glucose/pharmacokinetics , Insulin/metabolism , Models, Biological , Administration, Intravenous , Datasets as Topic , Glucose/administration & dosage , Glucose/metabolism , Glucose Tolerance Test , Healthy Volunteers , Homeostasis , Humans , Nonlinear Dynamics , Software , Time Factors
7.
AAPS J ; 21(3): 37, 2019 03 08.
Article in English | MEDLINE | ID: mdl-30850918

ABSTRACT

We investigated the possible advantages of using linearization to evaluate models of residual unexplained variability (RUV) for automated model building in a similar fashion to the recently developed method "residual modeling." Residual modeling, although fast and easy to automate, cannot identify the impact of implementing the needed RUV model on the imprecision of the rest of model parameters. We used six RUV models to be tested with 12 real data examples. Each example was first linearized; then, we assessed the agreement in improvement of fit between the base model and its extended models for linearization and conventional analysis, in comparison to residual modeling performance. Afterward, we compared the estimates of parameters' variabilities and their uncertainties obtained by linearization to conventional analysis. Linearization accurately identified and quantified the nature and magnitude of RUV model misspecification similar to residual modeling. In addition, linearization identified the direction of change and quantified the magnitude of this change in variability parameters and their uncertainties. This method is implemented in the software package PsN for automated model building/evaluation with continuous data.


Subject(s)
Chemistry, Pharmaceutical/methods , Models, Biological , Datasets as Topic , Nonlinear Dynamics , Software , Uncertainty
8.
Biosensors (Basel) ; 9(1)2019 Feb 18.
Article in English | MEDLINE | ID: mdl-30781627

ABSTRACT

Chitosan-tripolyphosphate nanoparticles (C-TPP NPs) were synthesized to investigate their cytotoxicity against colon cancer cells (Caco2 cells) in the absence and the presence of a near-infrared (NIR) laser to evaluate their influence in cancer detection using the NIR laser and to evaluate the NIR laser on cancer treatment. The synthesized NPs were characterized by Fourier transform infrared (FT-IR) spectroscopy, dynamic light scattering (DLS), zeta potential (ZP), and transmission electronic microscope (TEM). The cytotoxicity was analyzed by the MTT test and the cell viability was assessed using the Trypan blue method. C-TPP NPs showed increased cytotoxicity and decreased cell viability against Caco2 cells. Upon laser exposure only, the cell viability decreased. The C-TPP NPs appeared to have a shining light on the cancerous cells which were photographed under the inverted microscope.


Subject(s)
Chitosan/chemistry , Lasers , Nanoparticles/chemistry , Neoplasms/diagnostic imaging , Neoplasms/therapy , Spectroscopy, Near-Infrared , Caco-2 Cells , Cell Survival , Green Chemistry Technology , Humans , Inhibitory Concentration 50 , Nanoparticles/ultrastructure , Neoplasms/pathology , Particle Size , Spectroscopy, Fourier Transform Infrared , Static Electricity
9.
Parasitol Res ; 117(12): 3867-3880, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30280220

ABSTRACT

Schistosomiasis seriously affects human health in tropical regions. Its prevention is more important than treatment, raising the need for effective control methods. Recently, the role of nanomaterials in medical science has been growing. The present study aimed to evaluate the potential effects of silver (Ag) and gold (Au) nanoparticles (NPs) on Biomphalaria alexandrina snails and Schistosoma mansoni cercariae in vitro and to assess their effects on the infectivity of cercariae in vivo. The in vitro study proved that Ag and Au NPs were effective in killing B. alexandrina snails, with 30 µg/ml Ag and 160 µg/ml Au causing 100% mortality. The LC50 of 9.68 µg/ml for Ag NPs and 133.7 µg/ml for Au NPs prevented snail infection with S. mansoni miracidia. Furthermore, Ag NPs at 50 µg/ml and Au NPs at 100 µg/ml increased the mortality of S. mansoni cercariae in a dose- and time-dependent manner, reaching 100% mortality after 1 h. The in vivo study found that Ag NPs prevented the occurrence of infection when cercariae were treated before the infection by either the tail immersion (TI) or subcutaneous (SC) route, as proven by parasitological parameters and by the absence of granuloma formation in hepatic tissue. Meanwhile, infection of mice by untreated cercariae followed by treatment with NPs 1 h post-infection (PI) caused a decrease in egg count/g intestine and egg count/g liver in the TI-infected group only. The oogram patterns and granuloma formation results were similar between infection control and the SC-infected group. On the other hand, Au NPs led to a decrease in total worm burden (TWB) in all tested groups, with a decrease in egg count/g intestine and egg count/g liver in TI-infected groups with either pre-treated or post-treated cercariae, in contrast to SC-infected groups. However, the oogram patterns and granuloma formation showed similar results to infection control. Ag and Au NPs have potential as molluscicides and cercaricides in vitro and can prevent or modulate the infectivity of cercariae in vivo.


Subject(s)
Cercaria/drug effects , Gold/therapeutic use , Metal Nanoparticles/therapeutic use , Schistosoma mansoni/drug effects , Schistosomiasis mansoni/drug therapy , Schistosomiasis mansoni/prevention & control , Silver/therapeutic use , Animals , Biomphalaria/drug effects , Biomphalaria/parasitology , Humans , Injections, Subcutaneous , Liver/parasitology , Mice , Molluscacides/pharmacology , Parasite Egg Count , Parasite Load , Schistosomiasis mansoni/parasitology
10.
AAPS J ; 20(5): 81, 2018 07 02.
Article in English | MEDLINE | ID: mdl-29968184

ABSTRACT

The purpose of this study was to investigate if model-based post-processing of common diagnostics can be used as a diagnostic tool to quantitatively identify model misspecifications and rectifying actions. The main investigated diagnostic is conditional weighted residuals (CWRES). We have selected to showcase this principle with residual unexplained variability (RUV) models, where the new diagnostic tool is used to scan extended RUV models and assess in a fast and robust way whether, and what, extensions are expected to provide a superior description of data. The extended RUV models evaluated were autocorrelated errors, dynamic transform both sides, inter-individual variability on RUV, power error model, t-distributed errors, and time-varying error magnitude. The agreement in improvement in goodness-of-fit between implementing these extended RUV models on the original model and implementing these extended RUV models on CWRES was evaluated in real and simulated data examples. Real data exercise was applied to three other diagnostics: conditional weighted residuals with interaction (CWRESI), individual weighted residuals (IWRES), and normalized prediction distribution errors (NPDE). CWRES modeling typically predicted (i) the nature of model misspecifications, (ii) the magnitude of the expected improvement in fit in terms of difference in objective function value (ΔOFV), and (iii) the parameter estimates associated with the model extension. Alternative metrics (CWRESI, IWRES, and NPDE) also provided valuable information, but with a lower predictive performance of ΔOFV compared to CWRES. This method is a fast and easily automated diagnostic tool for RUV model development/evaluation process; it is already implemented in the software package PsN.


Subject(s)
Drug Development/methods , Drug Monitoring/methods , Models, Biological , Pharmacokinetics , Toxicokinetics , Computer Simulation , Humans , Nonlinear Dynamics , Reproducibility of Results , Risk Assessment , Software
11.
CPT Pharmacometrics Syst Pharmacol ; 7(7): 432-441, 2018 07.
Article in English | MEDLINE | ID: mdl-29732710

ABSTRACT

In antidiabetic drug development, phase I studies usually involve short-term glucose provocations. Multiple designs are available for these provocations (e.g., meal tolerance tests (MTTs) and graded glucose infusions (GGIs)). With a highly nonlinear, complex system as the glucose homeostasis, the various provocations will contribute with different information offering a rich choice. Here, we investigate the most appropriate study design in phase I for several hypothetical mechanisms of action of a study drug. Five drug effects in diabetes therapeutic areas were investigated using six study designs. Power to detect drug effect was assessed using the likelihood ratio test, whereas precision and accuracy of the quantification of drug effect was assessed using stochastic simulation and estimations. An overall summary was developed to aid designing the studies of antihyperglycemic drug development using model-based analysis. This guidance is to be used when the integrated glucose insulin model is used, involving the investigated drug mechanisms of action.


Subject(s)
Drug Development/methods , Glucose Tolerance Test , Hypoglycemic Agents/therapeutic use , Blood Glucose/metabolism , Clinical Trials, Phase I as Topic , Humans , Likelihood Functions , Models, Biological , Research Design , Stochastic Processes
12.
Eur J Pharm Sci ; 109: 253-261, 2017 Nov 15.
Article in English | MEDLINE | ID: mdl-28821435

ABSTRACT

Though numerous reports have demonstrated multiple mechanisms by which furosemide can exert its anti-hypertensive response. However, lack of studies describing PK-PD relationship for furosemide featuring its anti-hypertensive property has limited its usage as a blood pressure (BP) lowering agent. Serum concentrations and mean arterial BP were monitored following 40 and 80mgkg-1 multiple oral dose of furosemide in spontaneously hypertensive rats (SHR) and DOCA-salt induced hypertensive (DOCA-salt) rats. A simultaneous population PK-PD relationship using Emax model with effect compartment was developed to compare the anti-hypertensive efficacy of furosemide in these rat models. A two-compartment PK model with Weibull-type absorption and first-order elimination best described the serum concentration-time profile of furosemide. In the present study, post dose serum concentrations of furosemide were found to be lower than the EC50. The EC50 predicted in DOCA-salt rats was found to be lower (4.5-fold), whereas the tolerance development was higher than that in SHR model. The PK-PD parameter estimates, particularly lower values of EC50, Ke and Q in DOCA-salt rats as compared to SHR, pinpointed the higher BP lowering efficacy of furosemide in volume overload induced hypertensive conditions. Insignificantly altered serum creatinine and electrolyte levels indicated a favorable side effect profile of furosemide. In conclusion, the final PK-PD model described the data well and provides detailed insights into the use of furosemide as an anti-hypertensive agent.


Subject(s)
Antihypertensive Agents/pharmacokinetics , Blood Pressure/drug effects , Diuretics/pharmacokinetics , Furosemide/pharmacokinetics , Hypertension , Models, Biological , Animals , Antihypertensive Agents/blood , Antihypertensive Agents/pharmacology , Diuretics/blood , Diuretics/pharmacology , Furosemide/blood , Furosemide/pharmacology , Hypertension/drug therapy , Hypertension/metabolism , Hypertension/physiopathology , Male , Rats, Inbred SHR , Rats, Wistar
13.
Eur J Clin Microbiol Infect Dis ; 36(7): 1143-1150, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28155014

ABSTRACT

Lymphatic filariasis (LF) is focally endemic in Egypt where the female mosquito, Culex pipiens, is responsible for its transmission. The aim of the study was to investigate the impact of implementation of the 13th round of MDA in two Egyptian villages in the Menoufyia Governorate area after failing the transmission assessment survey (TAS) in 2005 using two methods, and to decide whether it is safe to stop MDA in these, as well as in similar implementation units (IUs). To achieve this aim, both the immunochromatographic card test (ICT) and molecular xenomonitoring (MX) techniques were employed. A cross-sectional study was carried out in the villages in 2014 with two sections: Section (1): a school-based survey where all the primary school entrants (6-7) years of age were tested by ICT. Section (2): a mosquito-based survey where a total of 152 mosquito pools collected from Samalay and 167 from Kafr El-Tarainah were tested for the presence of the gDNA of Wuchereria bancrofti microfilaria by real-time PCR assays. The results revealed that all primary school children in both villages were 100% negative for antigenemia. Also, all mosquito pools were 100% negative for the microfilarial gDNA.


Subject(s)
Disease Transmission, Infectious/prevention & control , Elephantiasis, Filarial/epidemiology , Elephantiasis, Filarial/transmission , Filaricides/administration & dosage , Mass Drug Administration , Animals , Child , Chromatography, Affinity , Cross-Sectional Studies , Egypt/epidemiology , Female , Humans , Male , Mosquito Vectors/parasitology , Real-Time Polymerase Chain Reaction , Surveys and Questionnaires , Wuchereria bancrofti/genetics , Wuchereria bancrofti/isolation & purification
14.
Pediatr Hematol Oncol ; 32(5): 304-14, 2015.
Article in English | MEDLINE | ID: mdl-25871509

ABSTRACT

BACKGROUND: Respiratory viruses are widespread in the community and easily transmitted to immunocompromised patients. AIMS: Assess the prevalence of community-acquired respiratory viral infections among children with cancer presenting with clinical picture suggestive of lower respiratory tract infections (LRTIs), and evaluate its risk factors and prognosis. METHODS: Over a year, 90 hospitalized children with malignancy and LRTIs recruited, subjected to clinical assessment, investigated through hematology panel, blood culture, chest x-ray, CT chest and PCR for influenza A and B, parainfluenza (PIV) types 1 and 3 viruses, and respiratory syncytial virus (RSV), and prospectively followed up for the clinical outcome. RESULTS: Viral pathogens were identified in 34 patients (37.7%), with a seasonal peak from April to May. The most frequently detected virus was influenza virus [type A (16 cases; 47%), type B (4 cases; 12%)] followed by parainfluenza virus [PIV1 (9 cases; 26%), PIV3 (3 cases; 15%)], and none had RSV. Bacteria were identified in 26 patients, fungi in four, mixed infections [bacterial/viral and bacterial/fungal] in 13, and 36 cases had unidentified etiology. The majority of patients with influenza and parainfluenza infections had hematological malignancy, presented with fever, and had mild self-limited respiratory illness. Five patients with mixed viral and bacterial infection had severe symptoms necessitating ICU admission. Six patients died from infection-related sequelae; two had mixed PIV and Staphylococcal infections. CONCLUSIONS: Community acquired influenza and parainfluenza infections are common in pediatrics patients with malignancy, either as isolated or mixed viral/bacterial infections. Clinical suspicion is essential as hematological and radiological manifestations are nonspecific. Rapid diagnosis and management are mandatory to improve patients' outcome.


Subject(s)
Communicable Diseases/epidemiology , Hematologic Neoplasms/epidemiology , Influenza, Human/epidemiology , Paramyxoviridae Infections/epidemiology , Adolescent , Child , Child, Preschool , Communicable Diseases/diagnosis , Communicable Diseases/therapy , Egypt/epidemiology , Female , Humans , Infant , Influenza, Human/diagnosis , Influenza, Human/therapy , Male , Paramyxoviridae Infections/diagnosis , Paramyxoviridae Infections/therapy , Prospective Studies
15.
East Mediterr Health J ; 20(5): 295-9, 2014 Jun 09.
Article in English | MEDLINE | ID: mdl-24952286

ABSTRACT

The World Health Organization recommends that before lymphatic filariasis elimination in an area can be confirmed, an additional survey should be performed at least 5 years after stopping mass drug administration. The current study aimed to determine the status of lymphatic filariasis 5 years after cessation ofthe mass drug administration in 3 sentinel Egyptian villages in Menoufiya Governorate. The rapid immunochromatographic card test (ICT) and a new commercial antibody detection kit (CELISA®) were used. All 1321 primary-school children aged 6-7 years old were ICT negative but 27 children were antibody positive. All households surveyed in one village with the highest antibody prevalence were ICT negative, indicating an absence of lymphatic filariasis. The CELISA antibody kit needs more standardization and development to be useful under field conditions. We conclude that lymphatic filariasis is no longer a public health problem in these villages and other villages with similar epidemiological conditions.


Subject(s)
Anthelmintics/administration & dosage , Elephantiasis, Filarial/epidemiology , Elephantiasis, Filarial/prevention & control , Child , Egypt/epidemiology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Male , Population Surveillance , Prevalence , Time Factors
16.
Article in English | WHO IRIS | ID: who-250599

ABSTRACT

توصي منظمة الصحة العالمية بإجراء مسوحات إضافية بعد مرور 5 سنوات على الأقل على إيقاف الإعطاء الجموعي للأدوية قبل تأكيد التخلص من داء الخيطيات اللمفاوي. وتهدف الدراسة الحالية إلى التعرف على الوضع الذي آل إليه داء الخيطيات اللمفاوي بعد مرور 5 سنوات على إيقاف إعطاء الأدوية الجموعي في 3 قرى خافرة في محافظة المنوفية في مصر. واستخدم الباحثون اختبار البطاقة السريعة للاستشراب المناعي ICT، وحقيبة تجارية لكشف الأضداد هي سيليسا [CELISA[R]. واتضح للباحثين أن جميع الأطفال في المرحلة الابتدائية والذين تتراوح أعمارهم بين 6 - 7 سنوات وعددهم 1321 طفا كانوا سلبيين، وأن هناك 27 طفلا لديهم إيجابية في الأضداد. كما أن جميع الأسر التي أجري المسح عليها في إحدى القرى التي كانت الأعلى من حيث معدل انتشار الأضداد كانوا سلبيين باختبار البطاقة السريعة الاستشراب المناعي، مما يشير إلى غياب داء الخيطيات اللمفاوي. أما حقيبة سيليسا التجارية فتحتاج إلى المزيد من المعايرة والتطور حتى تصبح مفيدة في العمل الميداني. واستنتج الباحثون أن داء الخيطيات اللمفاوي لم يعد من مشكلات الصحة العامة في هذه القرى وفي القرى الأخرى التي تشابهها في الظروف الوبائية


ABSTRACT The World Health Organization recommends that before lymphatic filariasis elimination in an area can be confirmed, an additional survey should be performed at least 5 years after stopping mass drug administration. The current study aimed to determine the status of lymphatic filariasis 5 years after cessation of the mass drug administration in 3 sentinel Egyptian villages in Menoufiya Governorate. The rapid immunochromatographic card test (ICT) and a new commercial antibody detection kit (CELISA®) were used. All 1321 primary-school children aged 6–7 years old were ICT negative but 27 children were antibody positive. All households surveyed in one village with the highest antibody prevalence were ICT negative, indicating an absence of lymphatic filariasis. The CELISA antibody kit needs more standardization and development to be useful under field conditions. We conclude that lymphatic filariasis is no longer a public health problem in these villages and other villages with similar epidemiological conditions.


RÉSUMÉ L'Organisation mondiale de la Santé recommande de mener une enquête supplémentaire au moins cinq ans après l'arrêt de l'administration massive de médicaments avant de confirmer l'élimination de la filariose lymphatique dans une zone donnée. La présente étude visait à déterminer le statut de la filariose lymphatique cinq ans après l'arrêt de l'administration massive de médicaments dans trois villages sentinelles égyptiens du Gouvernorat de Menoufiya. Le test immunochromatographique sur carte (ICT) rapide et un nouveau kit de détection d'anticorps commercial (CELISA®) ont été utilisés. L'ensemble des 1321 écoliers du primaire âgés de 6 à 7 ans avaient des résultats négatifs à l'ICT mais 27 enfants avaient des résultats positifs aux anticorps. Tous les ménages qui ont fait l'objet d'une enquête dans un village où la prévalence des anticorps était la plus élevée ont eu des résultats négatifs à l'ICT, ce qui indique une absence de filariose lymphatique. Le kit de détection d'anticorps CELISA doit faire l'objet d'un développement et d'une normalisation plus poussés pour être utile dans des conditions de terrain. Nous en concluons que la filariose lymphatique ne représente plus un problème de santé publique dans ces villages ainsi que dans d'autres villages ayant des conditions épidémiologiques similaires.


Subject(s)
Elephantiasis, Filarial , Child , Reagent Kits, Diagnostic , Chromatography, Affinity , Schools
17.
Environ Pollut ; 116(2): 185-91, 2002.
Article in English | MEDLINE | ID: mdl-11806446

ABSTRACT

The potential value of the marine prosobranch Nerita saxtilis as an efficient biological monitor to heavy metal pollution in the Red Sea was investigated. Storage ability of lead and cadmium was compared in shell, headfoot and digestive gland of the marine snail N. saxtilis collected from Al-Hamrauin area at El-kuseir (lead, 300.35 +/- 28.53 microg/l, 1,716 +/- 16.14. cadmium 20.01 +/- 1.8 microg/l, 161.72 +/- 21.4 mean +/- S.D. for water and sediment, respectively) relative to that of inhabiting marine water and sediment employing atomic absorption spectrometry to determine the organ with highest capability of heavy metal accumulation. The influence of metal storage on light microscopic structure of that organ was investigated. Also, the ultrastructure localization of storage sites in the same organ was determined employing transmission electron microscopy. The digestive gland was shown to accumulate both metals at conccntrations that are several orders of magnitude higher than those in the surrounding marine water. The bioaccumulation capability of lead and cadmium was ranked in the following order; digestive gland > headfoot > shell for lead and digestive gland > shell > headfoot for cadmium. In spite of its evident highest metal storage capability, no histopathological changes were observed in the digestive gland of that marine prosobranch. Enlarged electron dense vesicles and many granules were observed in ultrathin sections in digestive cells of these snails and are suggested to be the sites of storage of detoxified metals. The results of that finding indicate the possibility of using the marine prosobranch N. saxtilis as biomonitor for heavy metal contaminants in the Red Sea.


Subject(s)
Cadmium/pharmacokinetics , Lead/pharmacokinetics , Snails , Water Pollutants, Chemical/pharmacokinetics , Animals , Environmental Exposure , Microscopy, Electron , Tissue Distribution
18.
Article in English | MEDLINE | ID: mdl-11369301

ABSTRACT

We investigated the influence of exogenously administered melatonin on adult rats eye lenses exposed to ultraviolet radiation (UV) A and B ranging from 356-254 nm irradiation at 8 microW/cm(2). Rats exposed to this range of UV for 15 min for one week showed a significant (P<0.05) reduction in antioxidant enzymes activities; superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and elevated (P<0.001) lipid peroxidation served as an index of cellular damage by free radicals. UV-radiation significantly (P<0.001) elevated calcium ions (Ca(2+)) and lactate dehydrogenase (LDH) activity in lenses. Depleting animals of their stores of important intracellular antioxidant and elevating lenticular Ca(2+) by UV irradiation, may be the main cause of lens opacification. Melatonin injection with radiation significantly reduced (P<0.05) lipid peroxidation, Ca(2+) and (P<0.001) for LDH. When melatonin was injected after radiation, SOD and GSH-Px enzyme activities increased significantly (P<0.01), and lipid peroxidation, Ca(2+) levels and LDH activities were reduced significantly. Melatonin injection after UV radiation was as effective as melatonin treatment concurrent with UV irradiation. We conclude that melatonin may protect the eye lens from the damaging effects of UV exposure, and its actions protect lens from oxidative stress, elevating Ca(2+) levels, which are considered as an important causes of cataractogenesis.


Subject(s)
Antioxidants/pharmacology , Lens, Crystalline/drug effects , Melatonin/pharmacology , Radiation-Protective Agents/pharmacology , Ultraviolet Rays , Animals , Biological Assay , Calcium/metabolism , Cataract/etiology , Cataract/metabolism , Glutathione Peroxidase/metabolism , L-Lactate Dehydrogenase/metabolism , Lens, Crystalline/metabolism , Lens, Crystalline/radiation effects , Lipid Peroxidation/drug effects , Male , Oxidative Stress , Rats , Rats, Sprague-Dawley , Superoxide Dismutase/metabolism , Ultraviolet Rays/adverse effects
19.
J Egypt Soc Parasitol ; 30(1): 69-81, 2000 Apr.
Article in English | MEDLINE | ID: mdl-10786020

ABSTRACT

This study shows that Toxoplasma gondii infection is capable of inducing a process of programmed cell death not only in the infected hepatocytes of experimental murine model, but also the neighbouring non-infected cells. However, some cells showed a possible mixed apoptotic and necrotic pattern. Surprisingly, lymphocytes and Kupffer cells in portal sinusoids nearby the parasite vacuoles showed no apparent changes. Toxoplasma in concomitant infection with a different parasite, Trichinella spiralis, clearly mitigate the pathologic and apoptotic changes caused by T. gondii. These findings might help in understanding the problematic biology and immunopathogenesis of T. gondii. The results also augments previous reports by the same authors about the possible protective role of heterologous antigens of one parasite against a biologically and immunologically different parasite.


Subject(s)
Apoptosis , Toxoplasmosis, Animal/complications , Trichinellosis/complications , Animals , Female , Mice , Microscopy, Electron , Trichinella spiralis
20.
J Egypt Soc Parasitol ; 29(3): 963-78, 1999.
Article in English | MEDLINE | ID: mdl-12561934

ABSTRACT

Mixed parasitic infections have been long seen as a double impact on the host. In this study a different view of polyparasitism is demonstrated. The influence of the immunological environments created by two biologically different parasites on the pathogenesis of each other was evaluated. Swiss albino mice were sequentially infected with the intracellular protozoan Toxoplasma gondii (acute and latent), which elicits a T-helper 1 (Th1)-polarized immune response and the helminth parasite Trichinella spiralis, whose infection is predominated by a Th2 response. The results show a significant heterologous protection from one parasite towards the other. There was a highly significant lower Trichinella muscle larvae burden in mixed infection group compared to single Trichinella infection, in spite of delayed intestinal adult worm expulsion in the mixed infection group. A highly significant lower burden of T. gondii brain cysts in mixed infection compared to single latent Toxoplasma infection was also demonstrated. Concerning the anti-Toxoplasma antibody response, there was a significant lower levels in the latent Toxo-Trich. group compared to the group of latent toxoplasmosis only. These significant lower antibody titers were reproducible by two different assays; dye test and direct agglutination test.


Subject(s)
Toxoplasma/immunology , Toxoplasmosis, Animal/complications , Toxoplasmosis, Animal/immunology , Trichinella spiralis/immunology , Trichinellosis/complications , Trichinellosis/immunology , Animals , Antibodies, Helminth/blood , Antibodies, Protozoan/blood , Brain/parasitology , Disease Models, Animal , Female , Humans , Mice , Muscles/parasitology , Toxoplasmosis, Animal/parasitology , Trichinellosis/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL
...